nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—EDNRA—Signaling by GPCR—IHH—osteoarthritis	0.00305	0.00305	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MCF2L—osteoarthritis	0.00305	0.00305	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—CXCL8—osteoarthritis	0.00303	0.00303	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CAMK2B—osteoarthritis	0.00301	0.00301	CbGpPWpGaD
Irbesartan—JUN—FGF signaling pathway—MMP9—osteoarthritis	0.00294	0.00294	CbGpPWpGaD
Irbesartan—PTGS1—Overview of nanoparticle effects—IL6—osteoarthritis	0.00294	0.00294	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—osteoarthritis	0.00285	0.00285	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—IGF1—osteoarthritis	0.00284	0.00284	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—CXCL8—osteoarthritis	0.00284	0.00284	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—osteoarthritis	0.0028	0.0028	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—SMAD3—osteoarthritis	0.0028	0.0028	CbGpPWpGaD
Irbesartan—JUN—FAS pathway and Stress induction of HSP regulation—TNF—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—TNF—osteoarthritis	0.00276	0.00276	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.00275	0.00275	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.00271	0.00271	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—CXCL8—osteoarthritis	0.00264	0.00264	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—MCF2L—osteoarthritis	0.00264	0.00264	CbGpPWpGaD
Irbesartan—JUN—IL-3 Signaling Pathway—TGFB1—osteoarthritis	0.00262	0.00262	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.00257	0.00257	CbGpPWpGaD
Irbesartan—JUN—LPA receptor mediated events—MMP9—osteoarthritis	0.00256	0.00256	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1A—osteoarthritis	0.00256	0.00256	CbGpPWpGaD
Irbesartan—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.00255	0.00255	CbGpPWpGaD
Irbesartan—JUN—AGE/RAGE pathway—MMP9—osteoarthritis	0.0025	0.0025	CbGpPWpGaD
Irbesartan—PTGS1—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00249	0.00249	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—MMP1—osteoarthritis	0.00247	0.00247	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—osteoarthritis	0.00247	0.00247	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—TGFB1—osteoarthritis	0.00242	0.00242	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1A—osteoarthritis	0.00241	0.00241	CbGpPWpGaD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.0024	0.0024	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IHH—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MCF2L—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—TGFB1—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—MMP9—osteoarthritis	0.00239	0.00239	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.00237	0.00237	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—osteoarthritis	0.00237	0.00237	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—CRP—osteoarthritis	0.00236	0.00236	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.00233	0.00233	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Receptor Signaling—TNF—osteoarthritis	0.00226	0.00226	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—FN1—osteoarthritis	0.00225	0.00225	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—TNF—osteoarthritis	0.00223	0.00223	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—IL6—osteoarthritis	0.00223	0.00223	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL1A—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—MMP1—osteoarthritis	0.00222	0.00222	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—IL6—osteoarthritis	0.00219	0.00219	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—GSTO1—osteoarthritis	0.00215	0.00215	CbGpPWpGaD
Irbesartan—JUN—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—osteoarthritis	0.00215	0.00215	CbGpPWpGaD
Irbesartan—CYP2C8—Metapathway biotransformation—GSTO1—osteoarthritis	0.00212	0.00212	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL1B—osteoarthritis	0.00207	0.00207	CbGpPWpGaD
Irbesartan—JUN—Integrated Breast Cancer Pathway—ESR1—osteoarthritis	0.00205	0.00205	CbGpPWpGaD
Irbesartan—JUN—IL6-mediated signaling events—IL6—osteoarthritis	0.00204	0.00204	CbGpPWpGaD
Irbesartan—EDNRA—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.00203	0.00203	CbGpPWpGaD
Irbesartan—JUN—Regulation of Telomerase—TGFB1—osteoarthritis	0.00201	0.00201	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—TGFB1—osteoarthritis	0.00197	0.00197	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.00195	0.00195	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—TNF—osteoarthritis	0.00193	0.00193	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—osteoarthritis	0.00191	0.00191	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.00191	0.00191	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.00187	0.00187	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.00183	0.00183	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—MMP2—osteoarthritis	0.00182	0.00182	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00181	0.00181	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IHH—osteoarthritis	0.0018	0.0018	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MCF2L—osteoarthritis	0.0018	0.0018	CbGpPWpGaD
Irbesartan—JUN—MAP kinase activation in TLR cascade—IL6—osteoarthritis	0.00177	0.00177	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.00176	0.00176	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—FMOD—osteoarthritis	0.00176	0.00176	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.00175	0.00175	CbGpPWpGaD
Irbesartan—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.00174	0.00174	CbGpPWpGaD
Irbesartan—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.00172	0.00172	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—LEP—osteoarthritis	0.00171	0.00171	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—IL6—osteoarthritis	0.0017	0.0017	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.0017	0.0017	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—FN1—osteoarthritis	0.00169	0.00169	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL1A—osteoarthritis	0.00168	0.00168	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.00166	0.00166	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CTSK—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—TGFB1—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Irbesartan—CYP2C8—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00161	0.00161	CbGpPWpGaD
Irbesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—osteoarthritis	0.00159	0.00159	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNF—osteoarthritis	0.00159	0.00159	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—PTGS2—osteoarthritis	0.00158	0.00158	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.00152	0.00152	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.00149	0.00149	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL6—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—IGF1—osteoarthritis	0.00148	0.00148	CbGpPWpGaD
Irbesartan—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL1B—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.00147	0.00147	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.00146	0.00146	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGES—osteoarthritis	0.00143	0.00143	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.00142	0.00142	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IHH—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MCF2L—osteoarthritis	0.00141	0.00141	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.0014	0.0014	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—CXCL8—osteoarthritis	0.00139	0.00139	CbGpPWpGaD
Irbesartan—JUN—DNA Damage Response (only ATM dependent)—TGFB1—osteoarthritis	0.00138	0.00138	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Irbesartan—EDNRA—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00136	0.00136	CbGpPWpGaD
Irbesartan—UGT1A3—NRF2 pathway—TGFB1—osteoarthritis	0.00135	0.00135	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—osteoarthritis	0.00134	0.00134	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1B—osteoarthritis	0.00133	0.00133	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—COL9A2—osteoarthritis	0.00132	0.00132	CbGpPWpGaD
Irbesartan—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.00131	0.00131	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—COL9A1—osteoarthritis	0.00128	0.00128	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.00127	0.00127	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1B—osteoarthritis	0.00126	0.00126	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.00123	0.00123	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.00122	0.00122	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL6—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—CXCL8—osteoarthritis	0.00121	0.00121	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—IL6—osteoarthritis	0.00119	0.00119	CbGpPWpGaD
Irbesartan—JUN—TGF-beta Signaling Pathway—TGFB1—osteoarthritis	0.00118	0.00118	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.00117	0.00117	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.00115	0.00115	CbGpPWpGaD
Irbesartan—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.00114	0.00114	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—IL6—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Irbesartan—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.00112	0.00112	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.00111	0.00111	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.0011	0.0011	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Irbesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—osteoarthritis	0.00107	0.00107	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IHH—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MCF2L—osteoarthritis	0.00106	0.00106	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—COL9A2—osteoarthritis	0.00104	0.00104	CbGpPWpGaD
Irbesartan—EDNRA—GPCR ligand binding—CXCL8—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—MMP3—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.00103	0.00103	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—IL6—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—GSTO1—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—COL9A1—osteoarthritis	0.00101	0.00101	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—FMOD—osteoarthritis	0.00099	0.00099	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—BGN—osteoarthritis	0.000977	0.000977	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000977	0.000977	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—osteoarthritis	0.000968	0.000968	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000952	0.000952	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	0.000951	0.000951	CbGpPWpGaD
Irbesartan—JUN—Immune System—CAMK2B—osteoarthritis	0.000939	0.000939	CbGpPWpGaD
Irbesartan—JUN—Immune System—CTSK—osteoarthritis	0.000939	0.000939	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—CXCL8—osteoarthritis	0.000913	0.000913	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—osteoarthritis	0.000912	0.000912	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000881	0.000881	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—BMP2—osteoarthritis	0.00088	0.00088	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000863	0.000863	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—osteoarthritis	0.000862	0.000862	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	0.000856	0.000856	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000847	0.000847	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000823	0.000823	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000814	0.000814	CbGpPWpGaD
Irbesartan—AGTR1—GPCR ligand binding—CXCL8—osteoarthritis	0.000812	0.000812	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—MMP3—osteoarthritis	0.00081	0.00081	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoarthritis	0.000809	0.000809	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGES—osteoarthritis	0.000807	0.000807	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000806	0.000806	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000806	0.000806	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—osteoarthritis	0.000785	0.000785	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—osteoarthritis	0.000781	0.000781	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—COL9A2—osteoarthritis	0.000776	0.000776	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—COL9A1—osteoarthritis	0.000753	0.000753	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—osteoarthritis	0.000751	0.000751	CbGpPWpGaD
Irbesartan—JUN—Immune System—HSPA5—osteoarthritis	0.000747	0.000747	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1RN—osteoarthritis	0.000727	0.000727	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—osteoarthritis	0.000706	0.000706	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—BMP2—osteoarthritis	0.000691	0.000691	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—osteoarthritis	0.000678	0.000678	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—FMOD—osteoarthritis	0.000639	0.000639	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—osteoarthritis	0.000638	0.000638	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP3—osteoarthritis	0.00061	0.00061	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—CXCL8—osteoarthritis	0.000585	0.000585	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—GSTO1—osteoarthritis	0.000568	0.000568	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—SMAD3—osteoarthritis	0.000552	0.000552	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—BGN—osteoarthritis	0.000551	0.000551	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—CXCL8—osteoarthritis	0.000531	0.000531	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—FMOD—osteoarthritis	0.000525	0.000525	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1A—osteoarthritis	0.000523	0.000523	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGES—osteoarthritis	0.000521	0.000521	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—FMOD—osteoarthritis	0.00052	0.00052	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—BMP2—osteoarthritis	0.000516	0.000516	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—osteoarthritis	0.000513	0.000513	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP3—osteoarthritis	0.000479	0.000479	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—LEP—osteoarthritis	0.000472	0.000472	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—CXCL8—osteoarthritis	0.000459	0.000459	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ESR1—osteoarthritis	0.000451	0.000451	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—FN1—osteoarthritis	0.000445	0.000445	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—FMOD—osteoarthritis	0.000445	0.000445	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—osteoarthritis	0.000437	0.000437	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—SMAD3—osteoarthritis	0.000433	0.000433	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGES—osteoarthritis	0.000428	0.000428	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGES—osteoarthritis	0.000424	0.000424	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—CXCL8—osteoarthritis	0.000417	0.000417	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IGF1—osteoarthritis	0.00039	0.00039	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—LEP—osteoarthritis	0.00037	0.00037	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—GSTO1—osteoarthritis	0.000367	0.000367	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGES—osteoarthritis	0.000362	0.000362	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP3—osteoarthritis	0.000358	0.000358	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—BGN—osteoarthritis	0.000356	0.000356	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000355	0.000355	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ESR1—osteoarthritis	0.000354	0.000354	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—FN1—osteoarthritis	0.000349	0.000349	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—FMOD—osteoarthritis	0.000343	0.000343	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—SMAD3—osteoarthritis	0.000324	0.000324	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—CXCL8—osteoarthritis	0.000314	0.000314	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IGF1—osteoarthritis	0.000306	0.000306	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—GSTO1—osteoarthritis	0.000301	0.000301	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—GSTO1—osteoarthritis	0.000299	0.000299	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—osteoarthritis	0.000298	0.000298	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—BGN—osteoarthritis	0.000292	0.000292	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—BGN—osteoarthritis	0.000289	0.000289	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—MMP9—osteoarthritis	0.000284	0.000284	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PTGS2—osteoarthritis	0.000281	0.000281	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGES—osteoarthritis	0.00028	0.00028	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—LEP—osteoarthritis	0.000277	0.000277	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—osteoarthritis	0.000274	0.000274	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—osteoarthritis	0.000273	0.000273	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ESR1—osteoarthritis	0.000264	0.000264	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—FN1—osteoarthritis	0.000261	0.000261	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—GSTO1—osteoarthritis	0.000255	0.000255	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—BGN—osteoarthritis	0.000247	0.000247	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—CXCL8—osteoarthritis	0.000246	0.000246	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—osteoarthritis	0.000234	0.000234	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TGFB1—osteoarthritis	0.000234	0.000234	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00023	0.00023	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IGF1—osteoarthritis	0.000229	0.000229	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—MMP9—osteoarthritis	0.000223	0.000223	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—GSTO1—osteoarthritis	0.000197	0.000197	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—BGN—osteoarthritis	0.000191	0.000191	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.000187	0.000187	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—CXCL8—osteoarthritis	0.000184	0.000184	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TGFB1—osteoarthritis	0.000183	0.000183	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—osteoarthritis	0.000176	0.000176	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—MMP9—osteoarthritis	0.000166	0.000166	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—osteoarthritis	0.00016	0.00016	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	0.00016	0.00016	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PTGS2—osteoarthritis	0.000158	0.000158	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—osteoarthritis	0.000138	0.000138	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TGFB1—osteoarthritis	0.000137	0.000137	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—osteoarthritis	0.000103	0.000103	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PTGS2—osteoarthritis	0.000102	0.000102	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PTGS2—osteoarthritis	8.39e-05	8.39e-05	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PTGS2—osteoarthritis	8.32e-05	8.32e-05	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PTGS2—osteoarthritis	7.11e-05	7.11e-05	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PTGS2—osteoarthritis	5.49e-05	5.49e-05	CbGpPWpGaD
